Browsing School of Biomedical Engineering by Subject "absorption; bioavailability; cancer cell; cancer mortality; cancer radiotherapy; cancer recurrence; cancer surgery; cancer tissue; chemotherapy; clinical study; degradation; diagnostic imaging; DNA repair; drug metabolism; drug targeting; epigenetic modification; extravasation; human; immunotherapy; malignant neoplasm; metastasis; multidrug resistance; nanomedicine; phase 1 clinical trial (topic); phase 2 clinical trial (topic); recurrence risk; Review; solubility; theranostic nanomedicine; therapeutic index; tumor suppressor gene; drug delivery system; metabolism; neoplasm; personalized medicine; procedures"

Browsing School of Biomedical Engineering by Subject "absorption; bioavailability; cancer cell; cancer mortality; cancer radiotherapy; cancer recurrence; cancer surgery; cancer tissue; chemotherapy; clinical study; degradation; diagnostic imaging; DNA repair; drug metabolism; drug targeting; epigenetic modification; extravasation; human; immunotherapy; malignant neoplasm; metastasis; multidrug resistance; nanomedicine; phase 1 clinical trial (topic); phase 2 clinical trial (topic); recurrence risk; Review; solubility; theranostic nanomedicine; therapeutic index; tumor suppressor gene; drug delivery system; metabolism; neoplasm; personalized medicine; procedures"

Sort by: Order: Results:

  • Ligand conjugated lipid-based nanocarriers for cancer theranostics 
    Kumar, Rahul; Dkhar, Daphika S.; Kumari, Rohini; Divya; Mahapatra, Supratim; Srivastava, Ananya; Dubey, Vikash Kumar; Chandra, Pranjal (John Wiley and Sons Inc, 2022-11)
    Cancer is one of the major health-related issues affecting the population worldwide and subsequently accounts for the second-largest death. Genetic and epigenetic modifications in oncogenes or tumor suppressor genes affect ...

Search in IDR


Advanced Search

Browse

My Account